PCM
AIMT

Pentwater Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Pentwater Capital Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,501,200
Closed -$86.2M – 256
2020
Q3 		$86.2M Buy
+2,501,200
New +$86.2M 1.11% 16